Omega‐3 fatty acid plus vitamin D reduced high‐sensitivity CRP while increased total antioxidant capacity and glutathione; it also decreased the incidences of newborns' hyperbilirubinemia and hospitalization compared with other treatments. This evidence concerns the gene CRP and Hyperbilirubinemia.